Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Latest filing published 20 Apr 2026 for Ultragenyx Pharmaceutical Inc..
Filing timeline
BuySaleDennis Karl Huang
Insider track record
Disclosed buys
0
Disclosed sells
7
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Dennis Karl Huang: trading record in brief
Dennis Karl Huang is a declared insider of Ultragenyx Pharmaceutical Inc. (senior executive), with filings sourced from SEC (Form 4). Over a trading history stretching from 5 May 2015 to 16 April 2026, the count stands at 47 filings.
No open-market purchase appears, only 7 sales worth €810k. Outside the open market, there are 39 share grants.
The latest filing, published on 20 April 2026, reports a share grant in Ultragenyx Pharmaceutical Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Dennis Karl Huang
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
23,116 shares0Common StockSEC:0001193125-26-164297:0
11,137 shares0Common StockSEC:0001193125-26-089102:0
14,494 shares0Common StockSEC:0000950170-25-032767:0
17,800 shares0Common StockSEC:0000950170-24-026652:0
2,663 shares0Common StockSEC:0001209191-23-016043:0
3,234 shares@ US$66.620.0078% mcap61.8% of flowCommon StockSEC:0001209191-22-015815:0
358 shares@ US$81.1410.0% of flowCommon StockSEC:0001209191-21-060759:0
363 shares@ US$113.6813.6% of flowCommon StockSEC:0001209191-21-031390:0
8 of 8 declarations
